The field of Multiple Sclerosis (MS) and related disorders is a very rapidly evolving field of diagnostics and therapeutics. Every year, more treatments become available and new disease entities are being described. It is very difficult for healthcare providers to stay up to date with such changes. Thus, this educational activity aims to provide up to date value education for attendee. There are limited clinical trials in pediatric population with care of children largely being modeled after research and treatment in adult neuroimmunology cases and collaborative efforts are needed to educate both sides as well as the community. Especially that multiple sclerosis and related disorders can present differently in the adult versus pediatric populations. And a gap of knowledge regarding transition of pediatric patients with MS and related disorders to the adult stage in life and what is needed to assure smooth transition of clinical care and disease understanding. Identification of rare neuroimmuniological disease remains an unmet need and helping healthcare providers understand common and rare presentations of such diseases is at the utmost of importance given the potential for rapid and effective treatment.
July Theme: Treatment of MS
Key Words:
- Neurology
- Immunology
- Multiple Sclerosis
- MS
- Case
- Case-based
- Neuroimmunology
- Rare Disease
- Pediatric
- Adult
- Identification
- Clinical Trials
- Effective Treatment
- Physicians
- Residents/Fellows
- Advanced Practice Providers
- Medical Students (No Credit Provided)
Participants who engage in this educational intervention will be able to:
- Identify common and uncommon presentations of multiple sclerosis and related disorders
- Discuss the mechanism of disease modification via current and future therapeutics
- Identify common manifestations and initial diagnostic work-up of neuroimmunologic disease in children
In accordance with the ACCME® Standards for Integrity and Independence in Accredited Continuing Education, Standard 3, all in control of content must disclose any relevant financial relationships. The following in control of content had no relevant financial relationships to disclose.
Speaker:
Ahmed Obeidat, MD, PhD
Assistant Professor
Department of Neurology
Neuroimmunology and Multiple Sclerosis
Director, Neuroimmunology and MS Fellowship Program
The Medical College of Wisconsin
Activity Director:
Lileth Mondok, MD
Assistant Professor
Associate Medical Director of General Neurology
Division of Pediatric Neurology
Department of Neurology, MCW
Contact
ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
AMA Credit Designation Statement:
The Medical College of Wisconsin designates this for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hours of Participation for Allied Health Care Professionals:
The Medical College of Wisconsin designates this activity for up to 1.00 hours of participation for continuing education for allied health professionals.
To join session, click below link on July14th at 12pm CST.
You can also copy and paste the Zoom link into the calendar invite below.
- 1.00 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 1.00 Hours of ParticipationHours of Participation credit.